Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism?

Huot, Philippe

Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism? [electronic resource] - The Journal of pharmacology and experimental therapeutics Oct 2011 - 2-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1521-0103

10.1124/jpet.111.184093 doi


Animals
Antiparkinson Agents--pharmacology
Dyskinesia, Drug-Induced--drug therapy
Humans
MPTP Poisoning--drug therapy
Parkinson Disease--drug therapy
Receptor, Serotonin, 5-HT1A--drug effects
Receptor, Serotonin, 5-HT2A--drug effects
Serotonin Agents--pharmacology
Synaptic Transmission--drug effects